None
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign the informed consent form; 2. Age between 18-35 years old; 3. Healthy population; 4. Be able to comply with the research and follow-up procedures.
Exclusion criteria
Exclusion criteria: 1. Have taken antibiotics or antifungal drugs within 30 days prior to enrollment. 2. Have taken probiotic products within 2 weeks prior to enrollment. 3. Have taken medications that may interfere with glucose and lipid metabolism (such as insulin, glibenclamide, indomethacin, phentolamine, furosemide, phenytoin sodium, cortisone, etc.) within 1 month prior to enrollment. 4. Suffer from diseases that affect glucose and lipid metabolism or gut microbiota (such as obesity, thyroid dysfunction, asthma, hypertension, diarrhea, inflammatory bowel disease, irritable bowel syndrome, history of gastrointestinal surgery, etc.). 5. Be smokers or alcohol consumers. 6. Be pregnant or lactating women. 7. Be judged by the researchers as unfit to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composition and abundance of gut bacteria; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood lipids;Blood glucose;Serum uric acid; | — |
Countries
China
Contacts
The third affiliated hospital of southern medical university